State Street’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

State Street’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-402,209	Closed	-$30.1M	–	3802
2015 Q3	$30.1M	Sell	402,209 -433,982	-52%	-$32.4M	﹤0.01%	1472
2015 Q2	$63M	Buy	836,191 +133,610	+19%	+$7.16M	0.01%	1127
2015 Q1	$35.2M	Sell	702,581 -26,235	-4%	-$1.1M	﹤0.01%	1445
2014 Q4	$25.3M	Buy	728,816 +67,446	+10%	+$2.35M	﹤0.01%	1637
2014 Q3	$21.7M	Buy	661,370 +29,978	+5%	+$1.06M	﹤0.01%	1683
2014 Q2	$24.2M	Buy	631,392 +71,661	+13%	+$2.5M	﹤0.01%	1680
2014 Q1	$22.3M	Buy	559,731 +6,649	+1%	+$297K	﹤0.01%	1697
2013 Q4	$20.6M	Buy	553,082 +423,179	+326%	+$17.6M	﹤0.01%	1721
2013 Q3	$5.94M	Buy	129,903 +55,157	+74%	+$1.65M	﹤0.01%	2433
2013 Q2	$2.02M	Buy	+74,746	New	+$1.71M	﹤0.01%	2984

State Street's KYTH Position: Q4 2015 in Review

State Street sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 402,209 shares — an estimated $30.1M sold.

State Street first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $63M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

State Street reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
State Street sold 402,209 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $30.1M.
State Street first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
State Street's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $63M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on State Street's 13F filing for Q4 2015, filed 16 Feb 2016.